期刊
PHARMACOGENOMICS
卷 16, 期 10, 页码 1119-1133出版社
FUTURE MEDICINE LTD
DOI: 10.2217/PGS.15.62
关键词
6-mercaptopurine; childhood acute lymphoblastic leukemia; leukopenia; neutropenia; pharmacogenetics; relapse
资金
- Grant office of the Faculty of Medicine, Assiut University, Egypt
- INSERM
- University of Limoges
We investigated the associations between variants in genes coding for enzymes and transporters related to the 6-mercaptopurine pathway and clinical outcomes in pediatric patients with acute lymphoblastic leukemia. Materials & methods: Statistical association between gender, age and genotypes of selected SNPs, and the risks of hematological toxicity and relapse were investigated using a Cox proportional hazard model in 70 acute lymphoblastic leukemia patients from upper Egypt. Results: We found significant associations between ITPA, IMPDH1, SLC29A1, SLC28A2, SLC28A3 and ABCC4 SNPs and one or more of the hematological toxicity manifestations (neutropenia, agranulocytosis and leukopenia); age was significantly related to relapse. Conclusion: Genetic polymorphisms in enzymes and transporters involved in the 6-mercaptopurine pathway should be considered during its use to avoid hematological toxicity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据